ClinicalTrials.Veeva

Menu

Effects of Deep Brain Stimulation of the Dentate Nucleus on Cerebellar Ataxia

U

University of Sao Paulo General Hospital

Status

Unknown

Conditions

Cerebellar Ataxia

Treatments

Device: deep brain stimulation off stimulation - sham
Device: deep brain stimulation on stimulation - active

Study type

Interventional

Funder types

Other

Identifiers

NCT03341416
102178/2015

Details and patient eligibility

About

Cerebellar ataxias are a group of disorders caused by cerebellar affections, for which currently no specific treatment is available. Some limited studies verified the effects of cerebellar transcranial magnetic stimulation (TMS) on ataxic symptoms, with good results. The hypothesis is that cerebellar TMS could improve ataxic symptoms in some patients and in these patients, chronic cerebellar stimulation through deep brain stimulation could be a therapeutic option. The rationale is to stimulate the dentate nucleus of the cerebellum in order to balance the functional asymmetry observed between both motor cortices after chronic cerebellar lesions.

Full description

Ten patients with cerebellar ataxia will be included in our protocol. Ataxia might be due to several aetiologies, from degenerative to genetic and vascular diseases. The initial focus is vascular and spinal cerebellar ataxias. The participants will be submitted to a neuronavigation protocol for the precise location of the dentate nucleus contralateral to the most symptomatic side. After that, the participants will be randomly assigned to 5 active or 5 placebo sessions of 1Hz TMS over the located area. After the first 5 sessions and a period of at least 4 weeks washout, the participants will cross over and receive other 5 sessions, active or sham. Clinical and video evaluations will be conducted before and after active and sham cluster of sessions. The good responders, i.e., with over than 30% of improvement after the active section will be eligible to bilateral dentate nucleus DBS. After that, again, a cross-over double blind on-off stimulation will be performed. Each period (on or 0ff-stimulation) will last 4 weeks.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with diagnosis of chronic cerebellar ataxia (> 6 months);
  2. Age ≥18 years;
  3. Be able to understand study protocol;
  4. Signed, written informed consent (approved by the Institutional Ethics Committee) obtained prior to any study procedure;
  5. Refractory symptoms response to first, second and third line pharmacological treatment;
  6. Daily living activities impaired because the ataxia;
  7. Be able to undergo surgery procedures.

Exclusion criteria

  1. Abuse of alcohol, drugs
  2. Known psychiatric conditions
  3. Contraindications to DBS
  4. Heart failure or cardiac disease that contraindicates surgery procedures;
  5. Pacemaker or other stimulators implanted active;
  6. Positive blood ß-HCG test for women;
  7. Other medical conditions demand hospitalization; Participation in other clinical studies at the same time;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

10 participants in 2 patient groups

Device - deep brain stimulation ON
Experimental group
Description:
Intervention type: device (deep brain stimulation of the dentate nucleus in cerebellum). The intervention is a device called deep brain stimulation bilaterally placed in the sub thalamic nucleus. The stimulation will remained turned ON during 3 months - phase 1 - blinded and continuous during the open-label phase
Treatment:
Device: deep brain stimulation on stimulation - active
Device - deep brain stimulation Sham
Sham Comparator group
Description:
Sham stimulation: device (deep brain stimulation of the dentate nucleus in cerebellum). Intervention type: device (deep brain stimulation of the dentate nucleus in cerebellum). The intervention is a device called deep brain stimulation bilaterally placed in the sub thalamic nucleus. During the sham stimulation the intervention will remained turned OFF during 3 months
Treatment:
Device: deep brain stimulation off stimulation - sham

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems